Chargement en cours...
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We evaluated the efficacy of lenalidomide as front-line therapy for older AML patients. In this phase 2 study, patients 60 years of age or older with...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3318598/ https://ncbi.nlm.nih.gov/pubmed/21051557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-07-297143 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|